The dosage market size value for Penicillins and Streptomycins in Poland shows fluctuations from 2013 to 2023. Notably, market values generally declined with sporadic growth periods, averaging a 1.38% annual decrease over the last five years. Specifically, the years 2021 to 2023 experienced a near-stagnant decrease, stabilizing in 2023 at $143.34 million.
Future trends to watch for include:
- Market adaptation to emerging antibiotic alternatives due to resistance concerns.
- Regulatory changes affecting market dynamics and drug accessibility.
- Potential growth linked to increased healthcare investment and antibiotic use in agriculture.
How does Poland rank in Penicillins and Streptomycins in Dosage Market Size Value?
| # | 33 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 4,303,400,000 | 2023 | +0.61% | +1.48% | View data |
| 2 | 2 United Kingdom | 730,000,000 | 2023 | -1.31% | -1.45% | View data |
| 3 | 3 France | 717,200,000 | 2023 | -1.91% | +0.034% | View data |
| 4 | 4 Italy | 622,330,000 | 2023 | -3.96% | -4.86% | View data |
| 5 | 5 Germany | 476,270,000 | 2023 | +1.03% | +1.1% | View data |
| 9 | 9 Canada | 209,600,000 | 2023 | -2.3% | +1.59% | View data |
| 10 | 10 Spain | 197,590,000 | 2023 | -1.96% | -2.19% | View data |
| 11 | 11 Poland | 143,340,000 | 2023 | -0.61% | -1.38% | |
| 12 | 12 South Africa | 142,320,000 | 2023 | -0.66% | -0.0042% | View data |
| 13 | 13 Belgium | 129,530,000 | 2023 | +1.01% | +0.63% | View data |
